Mike Lee
Angel Investor @ Redmile Group
Mike Lee is a Series A investor at Redmile Group focused on Apps and Biopharma. Mike Lee
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Mike Lee invests in
Stages Mike Lee invests in
Countries Mike Lee invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Apps 1 (33%)
- Biopharma 1 (33%)
- Life Science 1 (33%)
- Biotechnology 1 (33%)
- Pharmaceutical 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- Denmark 1 (33%)
- Germany 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. | $325M / Series B / Jul 09, 2019 | ||
| Too Good To Go fights food waste primarily through our app. | $6.8M / Venture - Series Unknown / Feb 05, 2019 | ||
| BioNTech is a next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. It contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. | $270M / Series A / Jan 04, 2018 |
Co-Investors
About Redmile Group
Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.
Redmile Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Robert Faulkner
Managing Director
|
|||
Gerard van Hamel Platerink
Managing Director
|
|||
|
Jeremy Green
Founder and Portfolio Manager
|
|||
|
Mike Lee
Managing Director/Co-Founder
|
|||
Ming Fang
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mike Lee invest in?
Mike Lee invests primarily in Apps, Biopharma and Life Science startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mike Lee?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mike Lee last invest?
The most recent investment recorded for Mike Lee closed in Jul 2019. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
